Abbott Laboratories (NYSE:ABT) released new late breaking clinical data on its advanced cardiac devices, focusing on pulsed ...
A smart T-shirt with the power of AI could in the future detect heart conditions as people go about their daily lives, thanks to research at Imperial College London. Currently, people with symptoms ...
An analysis of SPRINT trial data may recast disorders of left ventricular (LV) conduction, usually considered something to manage after the fact, as preventable. The study points to hypertension as a ...
Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction system pacing (CSP) ...
Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
New research highlights postnatal regeneration limits and pathological remodeling of the cardiac conduction system after myocardial infarction, uncovering mechanisms behind clinical arrhythmogenesis ...
MedPage Today on MSN
Novel ICD lead for conduction system pacing enters the arena
First-in-human report for UltiSynq CSP ICD lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results